FI962892A - Pyrrolopyridatsiinin johdannaiset - Google Patents

Pyrrolopyridatsiinin johdannaiset Download PDF

Info

Publication number
FI962892A
FI962892A FI962892A FI962892A FI962892A FI 962892 A FI962892 A FI 962892A FI 962892 A FI962892 A FI 962892A FI 962892 A FI962892 A FI 962892A FI 962892 A FI962892 A FI 962892A
Authority
FI
Finland
Prior art keywords
group
alkyl group
aryl
halogeno
cycloalkyl
Prior art date
Application number
FI962892A
Other languages
English (en)
Swedish (sv)
Other versions
FI962892A0 (fi
FI112488B (fi
Inventor
Tomio Kimura
Yoshimi Fujihara
Nobuhiko Shibakawa
Hiroshi Fujiwara
Etsuro Itoh
Keiji Matsunobu
Keiichi Tabata
Hiroshi Yasuda
Original Assignee
Sankyo Co
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co, Ube Industries filed Critical Sankyo Co
Publication of FI962892A0 publication Critical patent/FI962892A0/fi
Publication of FI962892A publication Critical patent/FI962892A/fi
Application granted granted Critical
Publication of FI112488B publication Critical patent/FI112488B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI962892A 1994-01-19 1996-07-18 Aryylialkyyli- tai heteroaryylialkyylisubstituoidut pyrrolopyridatsiinijohdannaiset FI112488B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP398894 1994-01-19
JP398894 1994-01-19
JP9500038 1995-01-18
PCT/JP1995/000038 WO1995019980A1 (fr) 1994-01-19 1995-01-18 Derive de pyrrolopyridazine

Publications (3)

Publication Number Publication Date
FI962892A0 FI962892A0 (fi) 1996-07-18
FI962892A true FI962892A (fi) 1996-09-16
FI112488B FI112488B (fi) 2003-12-15

Family

ID=11572411

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962892A FI112488B (fi) 1994-01-19 1996-07-18 Aryylialkyyli- tai heteroaryylialkyylisubstituoidut pyrrolopyridatsiinijohdannaiset

Country Status (19)

Country Link
US (1) US6063782A (fi)
EP (1) EP0742218B1 (fi)
KR (1) KR100361199B1 (fi)
CN (1) CN1044811C (fi)
AT (1) ATE229020T1 (fi)
AU (1) AU680998B2 (fi)
CZ (1) CZ283216B6 (fi)
DE (1) DE69529056T2 (fi)
DK (1) DK0742218T3 (fi)
ES (1) ES2185693T3 (fi)
FI (1) FI112488B (fi)
HK (1) HK1015609A1 (fi)
HU (1) HU225920B1 (fi)
MX (1) MX9602850A (fi)
NO (1) NO307300B1 (fi)
NZ (1) NZ278675A (fi)
PT (1) PT742218E (fi)
RU (1) RU2146257C1 (fi)
WO (1) WO1995019980A1 (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316429B1 (en) * 1997-05-07 2001-11-13 Sugen, Inc. Bicyclic protein kinase inhibitors
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
DE19836698A1 (de) * 1998-08-13 2000-02-17 Bayer Ag Verfahren zur Herstellung von fluorierten Benzylalkoholen und -aldehyden
TWI287014B (en) * 1999-06-15 2007-09-21 Sankyo Co Optically active pyrrolopyridazine compound
PL358014A1 (en) 2000-02-10 2004-08-09 Sankyo Company, Limited Pyrrolopyridazine compound
FR2849025B1 (fr) * 2002-12-20 2005-10-14 Rhodia Chimie Sa Esters d'allyle substitue par un groupe difluoromethylene, leur procede de synthese et leur utilisation
JP2003119140A (ja) * 2001-08-08 2003-04-23 Sankyo Co Ltd ピロロピリダジン化合物を含有する医薬
US20040242540A1 (en) * 2001-09-27 2004-12-02 Jawed Asrar Fungicidal composition and their applications in agriculture
AU2003266622A1 (en) * 2002-09-25 2004-04-19 Sankyo Company, Limited Medicinal composition for inhibiting increase in blood gastrin concentration
WO2004029057A1 (ja) * 2002-09-25 2004-04-08 Sankyo Company, Limited 内臓痛の治療または予防のための医薬組成物
WO2004080487A1 (ja) * 2003-03-13 2004-09-23 Eisai Co. Ltd. 歯ぎしりの予防剤または治療剤
WO2006025714A1 (en) * 2004-09-03 2006-03-09 Yuhan Corporation PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
ES2342478T3 (es) * 2004-09-03 2010-07-07 Yuhan Corporation Derivados de pirrolo(3,2-c)piridina y procedimiento para la preparacion de los mismos.
KR100958828B1 (ko) * 2004-09-03 2010-05-24 주식회사유한양행 피롤로[3,2-ｂ]피리딘 유도체 및 그의 제조방법
KR101137168B1 (ko) * 2005-03-09 2012-04-19 주식회사유한양행 피롤로［２,３-ｄ］피리다진 유도체 및 그의 제조방법
WO2007081030A1 (ja) * 2006-01-16 2007-07-19 Ube Industries, Ltd. ピロロピリダジノン化合物
CN101003537A (zh) * 2006-01-17 2007-07-25 上海恒瑞医药有限公司 吡咯并哒嗪类衍生物及其制备方法和用途
MX336731B (es) 2010-01-28 2016-01-28 Harvard College Composiciones y metodos para potenciar la actividad de proteasoma.
US9556166B2 (en) 2011-05-12 2017-01-31 Proteostasis Therapeutics, Inc. Proteostasis regulators
WO2014116228A1 (en) 2013-01-25 2014-07-31 President And Fellows Of Harvard College Usp14 inhibitors for treating or preventing viral infections
WO2015073528A1 (en) 2013-11-12 2015-05-21 Proteostasis Therapeutics, Inc. Proteasome activity enhancing compounds
AU2016207014B2 (en) * 2015-01-13 2020-07-16 Vivreon Biosciences, Llc Modulators of CA2+ release-activated CA2+ (CRAC) channels and pharmaceutical uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8901430D0 (en) * 1989-01-23 1989-03-15 Smithkline Beckman Intercredit Compounds
IL97931A0 (en) * 1990-04-27 1992-06-21 Byk Gulden Lomberg Chem Fab Pyridazine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
AU8712191A (en) * 1990-10-15 1992-05-20 Byk Gulden Lomberg Chemische Fabrik Gmbh New diazines
ES2133331T3 (es) * 1991-10-25 1999-09-16 Byk Gulden Lomberg Chem Fab Pirrolo-piridazinas con efectos protectores del estomago y de los intestinos.

Also Published As

Publication number Publication date
PT742218E (pt) 2003-02-28
EP0742218B1 (en) 2002-12-04
MX9602850A (es) 1997-06-28
US6063782A (en) 2000-05-16
EP0742218A4 (en) 1997-07-09
DK0742218T3 (da) 2003-01-13
DE69529056D1 (de) 2003-01-16
HK1015609A1 (en) 1999-10-15
EP0742218A1 (en) 1996-11-13
DE69529056T2 (de) 2003-11-13
RU2146257C1 (ru) 2000-03-10
HU225920B1 (en) 2008-01-28
ATE229020T1 (de) 2002-12-15
CZ283216B6 (cs) 1998-02-18
NZ278675A (en) 1997-07-27
CN1044811C (zh) 1999-08-25
NO307300B1 (no) 2000-03-13
NO962998D0 (no) 1996-07-18
FI962892A0 (fi) 1996-07-18
HU9601967D0 (en) 1996-09-30
KR100361199B1 (ko) 2003-04-16
CZ208496A3 (en) 1996-12-11
AU680998B2 (en) 1997-08-14
AU1465795A (en) 1995-08-08
FI112488B (fi) 2003-12-15
NO962998L (no) 1996-09-17
ES2185693T3 (es) 2003-05-01
WO1995019980A1 (fr) 1995-07-27
CN1143964A (zh) 1997-02-26
HUT77998A (hu) 1999-04-28

Similar Documents

Publication Publication Date Title
DE69529056D1 (de) Pyrrolopyridazin-derivate
IL205420A (en) Immunogoldular and Derivative Compounds, Pharmaceutical Compounds in the Treatment of Inflammatory Stomach and Gastrointestinal Disorders
DK0683773T3 (da) Hypolopidæmiske kondenserede 1,4-thiazepiner
DE69418704D1 (de) Anthranilsäure derivate
NO20015172L (no) 1-metyl-erytromycin-derivater
NO20014925L (no) Farmasöytiske forbindelser
HUT60274A (en) Process for producing thioalkyl thiocafalosporin derivatives and pharmaceutical compositions comprising such compounds as active ingredient
DK0882728T3 (da) 1-methylcarbapenemderivater
EP0808839A4 (en) EPOXYSUCCINAMIDE DERIVATIVES OR THEIR SALTS AND MEDICATIONS CONTAINING THEM
DK0974589T3 (da) Benzimidazolderivater og farmaceutiske acceptable salte deraf
TW244336B (fi)
DK0485219T3 (da) Lægemidler til forebyggelse og behandling af kredsløbsorgansygdomme indeholdende spiro-3-heteroazolidinforbindelser
HRP990130B1 (en) HALOGEN DERIVATIVES 9a-N-(N'-ARYLCARBAMOYL)- AND 9a-N-(N'-ARYLTHIOCARBAMOYL)-9-DEOXO-9a-AZA-9a OF HOMOERYTHROMYCIN A
AP2003002831A0 (en) Derivatives of etoposide and analogs, and pharmaceutical compositions containing them
CA2181553A1 (en) Pyrrolopyridazine derivatives
EP1197211A4 (en) CANCER PREVENTION AND TREATMENT ACTIVE INGREDIENTS